Walter M. Stadler to Genes, ras
This is a "connection" page, showing publications Walter M. Stadler has written about Genes, ras.
Connection Strength
0.028
-
Phase II study of the oral MEK inhibitor selumetinib in advanced acute myelogenous leukemia: a University of Chicago phase II consortium trial. Clin Cancer Res. 2014 Jan 15; 20(2):490-8.
Score: 0.028